Bulletin of Experimental Biology and Medicine

, Volume 119, Issue 4, pp 371–373 | Cite as

Effect of oxipine on the severity of anaphylactic shock and the ratio of lipid fractions in lymphocytes of allergic rabbits

  • G. A. Bazanov
  • L. D. Smirnov
Pharmacology and Toxicology


It is shown that oxipine (mexidol; a 3-hydroxypyridine-derived antioxidant) injected intravenously into rabbits in a dose of 10 or 25 mg/kg alleviates the severity of the anaphylactic reaction, lowers the anaphylactic index, and considerably reduces the percentage of anaphylaxic shock-induced mortality. The preparation causes changes in the ratio of the total lipid to phospholipid fractions of lymphocytes, which has distinctive features in intact, primed, and challenged animals. It is thought that the antiallergic effects of oxipine are connected with both inhibition of free-radical oxidation and with the ability of the preparation to alter receptor properties of the allergy target cells due to its effect on the lipid ensembles of the cell membranes.

Key Words

oxipine lymphocytes allergy total lipids phospholipids 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A. Wentzel,Theorie zufalliger Prozesse, Birkhauser (1979).Google Scholar
  2. 2.
    I. S. Gushchin and A. I. Zebrev,Immunologiya, No, 1, 5–9 (1985).Google Scholar
  3. 3.
    L. S. Zhukhorov and S. A. Golovanov,Lab. Delo No 11, 683–685 (1984).PubMedGoogle Scholar
  4. 4.
    V. D. Kalyaev, in:Aspects of Blood Transfusion and Clinical Medicine [in Russian], Vol. 3 (1965), pp. 194–196.Google Scholar
  5. 5.
    A. V. Kargapolov,Biokhimiya,46, No 4, 691–697 (1981).Google Scholar
  6. 6.
    M. Kates,Techniques of Lipidology, Elsevier (1972).Google Scholar
  7. 7.
    Kh. Mangol'd,Thin-Layer Chromatography [in Russian], Moscow (1967), pp. 140–185.Google Scholar
  8. 8.
    K. D. Pletsitnyi, E. V. Nikulin, M. A. Akserov,et al. Byull. Eksp. Biol. Med.,103, No 1, 43–45 (1987).CrossRefGoogle Scholar
  9. 9.
    P. V. Sergeev,Steroid Hormones [in Russian], Moscow (1984), pp. 116–197.Google Scholar
  10. 10.
    L. D. Smirnov and K. M. Dyumaev,Directed Search For Physiologically Active Substances [in Russian], Riga (1989), pp. 5–44,Google Scholar
  11. 11.
    G. N. Chetverikov,Allergic Reactions in Experimental and Clinical Settings [in Russian], Moscow (1986), pp. 6–24.Google Scholar
  12. 12.
    A. Boyum,Scand. J. Clin. Lab. Invest.,21, Suppl. 97, 77–89 (1968).Google Scholar
  13. 13.
    R. Catheact,Med. Hypotheses,21, No 3, 307–321 (1986).Google Scholar
  14. 14.
    J. Folch, M. Lees, and S. G. H. Staane,J. Biol. Chem.,226, 497–509 (1957).PubMedGoogle Scholar
  15. 15.
    S. Seldon, R. Weindruch, and R. Walford,Free Radicals, Aging, and Degenerative Diseases, New York (1986), pp. 427–456.Google Scholar
  16. 16.
    W. Weigle, C. Cochrane, and F. Dixon,J. Immunol.,85, No 5, 469–477 (1960).PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1995

Authors and Affiliations

  • G. A. Bazanov
    • 1
    • 2
  • L. D. Smirnov
    • 1
    • 2
  1. 1.Department of Pharmacology with a Course in Clinical PharmacologyTver' Medical InstituteStaraya Kupavna
  2. 2.All-Russian Research Center for the Safety of Biologically Active SubstancesStaraya Kupavna

Personalised recommendations